About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 25 record(s)
Req # A-2021-24940
Provide all emails sent to/from Tanya Potashnik from May 1, 2021, to December 19, 2021. Exclude media scans.Organization: Patented Medicine Prices Review Board Canada
April 2023
Nothing to report this month
Organization: National Defence and Canadian Forces Ombudsman
Req # A-2022-13654
Electronic copies of the following documents: 1. A copy of every advance ruling certificate (ARC) issued by the Board, including any reasons in support of the ARC issued by the Board. 2. A copy of the Notice and Comment issued by the Board in response to each of the ARCs. 3. A copy of the patentee's submissions (including any affidavits or other evidence) on each of the ARCs. The Board's ARC for Viread indicates that these submissions are available upon request. 4. A copy of the Board Staff's submissions (including any affidavits or other evidence) on each of the ARCs. Again, the Board's Viread ARC indicates that these are available upon request. 5. A copy of any other submissions received in response to the notice of and comment.Organization: Patented Medicine Prices Review Board Canada
July 2022
Req # A-2021-10765
Copies of all expense claims and receipts over $ 100.00 for Douglas Clark, Tanya Potashnik and Mitchell Levine. For each expense provide the name of the service provider/contractor, a description of the product or service rendered, the date, and the total amount of the expense. When those three items can not be provided in said format, provide the entirety of records (including receipts, purchase orders, and service contracts) pertaining to the expense.Organization: Patented Medicine Prices Review Board Canada
April 2022
Req # A-2021-10768
Copies of all communications between the PMPRB and Health Canada from May 22, 2021 to June 11, 2021.Organization: Patented Medicine Prices Review Board Canada
April 2022
Req # A-2021-10771
Copies of all emails or logs of media requests or contacts with the PMPRB and Douglas Clark between May 22, 2021 to June 11, 2021.Organization: Patented Medicine Prices Review Board Canada
April 2022
Req # A-2021-11082
Copies of all documents presented, and shared with participants related to the symposium organized by the PMPRB with academics during the week of May 31, 2021.Organization: Patented Medicine Prices Review Board Canada
July 2021
Req # A-2020-03991
Copies of all records, analysis, correspondence, discussions, briefings, memos and decisions, about the development of the PMPRB regulations involving individuals with a classification of AS-04 and above, PM-04 and above, EC-04 and above, and EX-all levels. Also include the Minister and Political staff; between January 2016 to February 2020.Organization: Patented Medicine Prices Review Board Canada
April 2021
Req # A-2020-03992
Copies of all analysis, correspondence, discussions, briefings and memos about the evaluation of stakeholder submissions for the PMPRB regulations (including submissions relating to the 2016 PMPRB guidelines modernization, the 2017 consultations on potential changes to the PMPRB regulations, Canada Gazette Part I, and Canada Gazette Part II) involving individuals with a classification of AS-04 and above, PM-04 and above, EC-04 and above, EX-all levels. Include the Minister and Political staff; between January 2016 to February 2020.Organization: Patented Medicine Prices Review Board Canada
April 2021
Req # A-2021-05507
Copies of all communications to/from Douglas Clark regarding the timelines of CADTH and pCPA's drug review process from June 1, 2019 to March 3, 2021.Organization: Patented Medicine Prices Review Board Canada
April 2021